The ongoing weakness in the Life Sciences sector is affecting DHR's performance. Additionally, rising operating costs are another worry.
We have just released a list explaining why 15 large-cap stocks are dropping significantly in 2025. In this article, we will examine how Danaher Corporation (NYSE:DHR) compares to other large-cap stocks that are also experiencing declines this year. The market has been losing the gains it made earlier in the year.
Danaher Corporation (NYSE:DHR) will participate in the TD Cowen 45th Annual Health Care Conference Call on March 5, 2025, at 10:30 AM ET. The call will feature Rainer Blair, the President and CEO of the company. Dan Brennan from TD Cowen will also be present, as he specializes in tools and diagnostics.
On February 25, 2025, Danaher Corporation (NYSE: DHR) announced that its President and CEO, Rainer M. Blair, will speak at the TD Cowen Healthcare Conference in Boston, Massachusetts. The presentation is scheduled for Wednesday, March 5, 2025, at 10:30 a.m.
On February 20, 2025, Danaher Corporation (NYSE: DHR) revealed that Charles Lamanna has been appointed to its Board of Directors and the Science & Technology Committee. Mr. Lamanna is currently the Corporate Vice President for Business & Industry Copilot at Microsoft (NASDAQ: MSFT), where he focuses on product innovation in AI-driven business applications, low-code platforms, and autonomous agents.
On February 20, 2025, Danaher Corporation (NYSE: DHR) revealed that its Board of Directors has approved a quarterly cash dividend of $0.32 per share for its common stock. This dividend will be paid on April 25, 2025, to those who are on record by March 28, 2025. This new amount shows an increase of 18.5% compared to the last dividend of $0.27.
Danaher Corp. has experienced some challenges in the market lately, but it still shows strong profit margins and impressive free cash flow, which indicates its ability to bounce back and grow in the future. The company's focus on smart investments, like buying back shares and making acquisitions, shows that management is aiming for long-term success, even with current negative market feelings. Additionally, Danaher's bioprocessing division is growing steadily, and the upcoming patent expiration is likely to increase demand for their life science products.
On Wednesday morning, Johnson Controls International's shares rose significantly, making it the top gainer in the S&P 500. This increase followed the company's first-quarter results, which exceeded expectations, and the announcement of a new CEO.
Royal Caribbean and Danaher are included in the Zacks Earnings Trends report.
We have just released a list of the 10 stocks that performed the worst on Wednesday. In this article, we will examine how Danaher Corporation (NYSE:DHR) ranked among these underperformers. The stock market fell on Wednesday, with all major indices ending lower, mainly due to losses in technology stocks.